MedTrace Logo

Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti® in Knee Cartilage Defects

NCT06249828 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2026-02-25

No results posted yet for this study

Summary

Subjects aged 50 to 65 years with knee cartilage defects will undergo microfracture treatment for cartilage regeneration and MegaCarti® will be applied.

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

MegaCarti®

MegaCarti® application after microfracture through athroscopic or incision surgery

PROCEDURE

Microfracture

Microfracture through athroscopic or incision surgery

Sponsors & Collaborators

  • L&C Bio

    lead INDUSTRY

Principal Investigators

  • Sunghwan kim · Yonsei University College of Medicine, Severance Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-22
Primary Completion
2025-12-13
Completion
2025-12-13

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06249828 on ClinicalTrials.gov